SKBI, joko, No I didn't listen to the CC... I saw another vaccine company talk about using some of their capacity to target animal vaccines and wondered if their might be, intially at least, overcapacity. I wasn't worried because SKBI had the industry contacts.
However, if what you say is right.. then it's more about getting things started up / education. I've got SKBI as doing $990,000 in vaccine revenues (not sure where number comes from) so it's still a big increase to the $6 Million... But, as you say, it's a big drop for missing Q1, and Q1 is their quietest quarter by a big margin.
rich